Found: 49
Select item for more details and to access through your institution.
Pharmacokinetic, pharmacodynamic and biomarker evaluation of transforming growth factor-β receptor I kinase inhibitor, galunisertib, in phase 1 study in patients with advanced cancer.
- Published in:
- 2015
- By:
- Publication type:
- Journal Article
Pharmacokinetic, pharmacodynamic and biomarker evaluation of transforming growth factor-β receptor I kinase inhibitor, galunisertib, in phase 1 study in patients with advanced cancer.
- Published in:
- Investigational New Drugs, 2015, v. 33, n. 2, p. 357, doi. 10.1007/s10637-014-0192-4
- By:
- Publication type:
- Article
Imatinib in Philadelphia chromosome-positive chronic phase CML patients: Molecular and cytogenetic response rates and prediction of clinical outcome.
- Published in:
- American Journal of Hematology, 2003, v. 73, n. 4, p. 249, doi. 10.1002/ajh.10364
- By:
- Publication type:
- Article
A Novel Approach to Determining Tumor Progression Using a Three-Site Pilot Clinical Trial of Spectroscopic MRI-Guided Radiation Dose Escalation in Glioblastoma.
- Published in:
- Tomography: A Journal for Imaging Research, 2023, v. 9, n. 1, p. 362, doi. 10.3390/tomography9010029
- By:
- Publication type:
- Article
Final Report on Clinical Outcomes and Tumor Recurrence Patterns of a Pilot Study Assessing Efficacy of Belinostat (PXD-101) with Chemoradiation for Newly Diagnosed Glioblastoma.
- Published in:
- Tomography: A Journal for Imaging Research, 2022, v. 8, n. 2, p. 688, doi. 10.3390/tomography8020057
- By:
- Publication type:
- Article
Clinical Trial Design and Development Work Group Within the Quantitative Imaging Network.
- Published in:
- Tomography: A Journal for Imaging Research, 2020, v. 6, n. 2, p. 60, doi. 10.18383/j.tom.2019.00022
- By:
- Publication type:
- Article
Velocity-Selective Arterial Spin Labeling Perfusion in Monitoring High Grade Gliomas Following Therapy: Clinical Feasibility at 1.5T and Comparison with Dynamic Susceptibility Contrast Perfusion.
- Published in:
- Brain Sciences (2076-3425), 2024, v. 14, n. 2, p. 126, doi. 10.3390/brainsci14020126
- By:
- Publication type:
- Article
BRAF V600E-Mutant Glioblastoma with Extracranial Metastases Responsive to Combined BRAF and MEK Targeted Inhibition: A Case Report.
- Published in:
- 2022
- By:
- Publication type:
- Case Study
Hemophagocytic Lymphohistiocytosis Secondary to PD-1 and IDO Inhibition in a Patient with Refractory Glioblastoma.
- Published in:
- Case Reports in Oncology, 2020, v. 13, n. 2, p. 508, doi. 10.1159/000507281
- By:
- Publication type:
- Article
Ipilimumab-Induced Enteritis without Colitis: A New Challenge.
- Published in:
- Case Reports in Oncology, 2016, v. 9, n. 3, p. 705, doi. 10.1159/000452403
- By:
- Publication type:
- Article
Widely metastatic IDH1-mutant glioblastoma with oligodendroglial features and atypical molecular findings: a case report and review of current challenges in molecular diagnostics.
- Published in:
- Diagnostic Pathology, 2019, v. 14, n. 1, p. N.PAG, doi. 10.1186/s13000-019-0793-5
- By:
- Publication type:
- Article
Comparison of enteral and parenteral methods of urine alkalinization in patients receiving high-dose methotrexate.
- Published in:
- Journal of Oncology Pharmacy Practice, 2017, v. 23, n. 1, p. 3, doi. 10.1177/1078155215610914
- By:
- Publication type:
- Article
Correction to: Preoperative patient-reported physical health-related quality of life predicts short-term postoperative outcomes in brain tumor patients.
- Published in:
- 2024
- By:
- Publication type:
- Correction Notice
Preoperative patient-reported physical health-related quality of life predicts short-term postoperative outcomes in brain tumor patients.
- Published in:
- Journal of Neuro-Oncology, 2024, v. 167, n. 3, p. 477, doi. 10.1007/s11060-024-04627-0
- By:
- Publication type:
- Article
Safety of temozolomide use in adult patients with renal dysfunction.
- Published in:
- Journal of Neuro-Oncology, 2022, v. 159, n. 3, p. 591, doi. 10.1007/s11060-022-04098-1
- By:
- Publication type:
- Article
Correction to: White matter changes in primary central nervous system lymphoma patients treated with high-dose methotrexate with or without rituximab.
- Published in:
- 2019
- By:
- Publication type:
- Correction Notice
White matter changes in primary central nervous system lymphoma patients treated with high-dose methotrexate with or without rituximab.
- Published in:
- Journal of Neuro-Oncology, 2019, v. 145, n. 3, p. 461, doi. 10.1007/s11060-019-03279-9
- By:
- Publication type:
- Article
Incidence and clinicopathologic features of H3 K27M mutations in adults with radiographically-determined midline gliomas.
- Published in:
- Journal of Neuro-Oncology, 2019, v. 143, n. 1, p. 87, doi. 10.1007/s11060-019-03134-x
- By:
- Publication type:
- Article
The consistency of neuropathological diagnoses in patients undergoing surgery for suspected recurrence of glioblastoma.
- Published in:
- Journal of Neuro-Oncology, 2019, v. 141, n. 2, p. 347, doi. 10.1007/s11060-018-03037-3
- By:
- Publication type:
- Article
Pre-radiation lymphocyte harvesting and post-radiation reinfusion in patients with newly diagnosed high grade gliomas.
- Published in:
- Journal of Neuro-Oncology, 2015, v. 124, n. 2, p. 307, doi. 10.1007/s11060-015-1841-y
- By:
- Publication type:
- Article
Limited detection of IgH gene rearrangements in plasma of patients with primary central nervous system lymphoma.
- Published in:
- Journal of Neuro-Oncology, 2013, v. 114, n. 3, p. 275, doi. 10.1007/s11060-013-1182-7
- By:
- Publication type:
- Article
Blood-based biomarkers for malignant gliomas.
- Published in:
- Journal of Neuro-Oncology, 2013, v. 113, n. 3, p. 345, doi. 10.1007/s11060-013-1144-0
- By:
- Publication type:
- Article
'Elderly' patients with newly diagnosed glioblastoma deserve optimal care.
- Published in:
- 2013
- By:
- Publication type:
- Letter
Use of personalized molecular biomarkers in the clinical care of adults with glioblastomas.
- Published in:
- Journal of Neuro-Oncology, 2012, v. 110, n. 2, p. 279, doi. 10.1007/s11060-012-0968-3
- By:
- Publication type:
- Article
Pre- and post-operative plasma glial fibrillary acidic protein levels in patients with newly diagnosed gliomas.
- Published in:
- Journal of Neuro-Oncology, 2012, v. 109, n. 1, p. 123, doi. 10.1007/s11060-012-0874-8
- By:
- Publication type:
- Article
Analysis of Circulating Tumor DNA to Confirm Somatic KRAS Mutations.
- Published in:
- JNCI: Journal of the National Cancer Institute, 2009, v. 101, n. 18, p. 1284, doi. 10.1093/jnci/djp240
- By:
- Publication type:
- Article
Patterns of bevacizumab use in patients with glioblastoma: an online survey among experts in neuro-oncology.
- Published in:
- Neuro-Oncology Practice, 2020, v. 7, n. 1, p. 52, doi. 10.1093/nop/npz022
- By:
- Publication type:
- Article
Pneumocystis jirovecii prophylaxis in patients treated for high-grade gliomas: a survey among neuro-oncologists.
- Published in:
- Neuro-Oncology Practice, 2019, v. 6, n. 4, p. 321, doi. 10.1093/nop/npy049
- By:
- Publication type:
- Article
Phase I study of procaspase-activating compound-1 (PAC-1) in the treatment of advanced malignancies.
- Published in:
- 2023
- By:
- Publication type:
- journal article
Repeatability of <sup>18</sup>F-FLT PET in a Multicenter Study of Patients with High-Grade Glioma.
- Published in:
- Journal of Nuclear Medicine, 2017, v. 58, n. 3, p. 393, doi. 10.2967/jnumed.116.178434
- By:
- Publication type:
- Article
Controversies in the Adjuvant Therapy of High-Grade Gliomas.
- Published in:
- Oncologist, 2011, v. 16, n. 3, p. 351, doi. 10.1634/theoncologist.2010-0335
- By:
- Publication type:
- Article
ASXL1 inactivation and reduced H3K27me3 across central nervous system tumors.
- Published in:
- Acta Neuropathologica, 2024, v. 148, n. 1, p. 1, doi. 10.1007/s00401-024-02785-z
- By:
- Publication type:
- Article
Methylated markers accurately distinguish primary central nervous system lymphomas (PCNSL) from other CNS tumors.
- Published in:
- Clinical Epigenetics, 2021, v. 13, n. 1, p. 1, doi. 10.1186/s13148-021-01091-9
- By:
- Publication type:
- Article
Phase I dose-escalation study of procaspase-activating compound-1 in combination with temozolomide in patients with recurrent high-grade astrocytomas.
- Published in:
- Neuro-Oncology Advances, 2023, v. 5, n. 1, p. 1, doi. 10.1093/noajnl/vdad087
- By:
- Publication type:
- Article
A multi-institutional pilot clinical trial of spectroscopic MRI-guided radiation dose escalation for newly diagnosed glioblastoma.
- Published in:
- Neuro-Oncology Advances, 2022, v. 4, n. 1, p. 1, doi. 10.1093/noajnl/vdac006
- By:
- Publication type:
- Article
CloneRetriever: An Automated Algorithm to Identify Clonal B and T Cell Gene Rearrangements by Next-Generation Sequencing for the Diagnosis of Lymphoid Malignancies.
- Published in:
- Clinical Chemistry, 2021, v. 67, n. 11, p. 1524, doi. 10.1093/clinchem/hvab141
- By:
- Publication type:
- Article
Chemotherapy for Treatment of Grade II Gliomas.
- Published in:
- 2014
- By:
- Publication type:
- Journal Article
Chemotherapy for Treatment of Grade II Gliomas.
- Published in:
- Oncology (08909091), 2014, v. 28, n. 12, p. 1036
- By:
- Publication type:
- Article
Role of Surgical Resection in Primary CNS Lymphoma: A Resurrected Discussion.
- Published in:
- 2014
- By:
- Publication type:
- Journal Article
Role of Surgical Resection in Primary CNS Lymphoma: A Resurrected Discussion.
- Published in:
- Oncology (08909091), 2014, v. 28, n. 7, p. 641
- By:
- Publication type:
- Article
Systemic Approach to Recurrent Primary CNS Lymphoma: Perspective on Current and Emerging Treatment Strategies.
- Published in:
- OncoTargets & Therapy, 2020, v. 13, p. 8323, doi. 10.2147/OTT.S192379
- By:
- Publication type:
- Article
Intratumoral concentrations of imatinib after oral administration in patients with glioblastoma multiforme.
- Published in:
- Journal of Neuro-Oncology, 2010, v. 97, n. 2, p. 241, doi. 10.1007/s11060-009-0008-0
- By:
- Publication type:
- Article
Mutations of IDH1 and IDH2 are not detected in brain metastases of colorectal cancer.
- Published in:
- Journal of Neuro-Oncology, 2009, v. 94, n. 2, p. 297, doi. 10.1007/s11060-009-9855-y
- By:
- Publication type:
- Article
Optimizing eligibility criteria and clinical trial conduct to enhance clinical trial participation for primary brain tumor patients.
- Published in:
- Neuro-Oncology, 2020, v. 22, n. 5, p. 601, doi. 10.1093/neuonc/noaa015
- By:
- Publication type:
- Article
Discovery of predictive biomarkers in malignant gliomas.
- Published in:
- Neuro-Oncology, 2019, v. 21, n. 9, p. 1089, doi. 10.1093/neuonc/noz120
- By:
- Publication type:
- Article
ACTR-06. INITIAL RESULTS OF A PHASE I STUDY OF PROCASPASE ACTIVATING CCOMPOUND-1 (PAC-1) IN COMBINATION WITH TEMOZOLOMIDE FOR RECURRENT MALIGNANT GLIOMA.
- Published in:
- Neuro-Oncology, 2018, v. 20, p. vi12, doi. 10.1093/neuonc/noy148.041
- By:
- Publication type:
- Article
ACTR-18. PHASE II TRIAL OF TEMOZOLOMIDE AND TRC 102, BASE EXCISION REPAIR INHIBITOR, IN BEVACIZUMAB NAÏVE GLIOBLASTOMA AT FIRST RECURRENCE.
- Published in:
- Neuro-Oncology, 2018, v. 20, p. vi15, doi. 10.1093/neuonc/noy148.052
- By:
- Publication type:
- Article
Timed sequential therapy of the selective T-type calcium channel blocker mibefradil and temozolomide in patients with recurrent high-grade gliomas.
- Published in:
- Neuro-Oncology, 2017, v. 19, n. 6, p. 845, doi. 10.1093/neuonc/nox020
- By:
- Publication type:
- Article
IDH‐mutant brainstem gliomas in adolescent and young adult patients: Report of three cases and review of the literature.
- Published in:
- Brain Pathology, 2021, v. 31, n. 4, p. 1, doi. 10.1111/bpa.12959
- By:
- Publication type:
- Article